Works matching IS 2005-0380 AND VI 34 AND IP 4 AND DT 2023
Results: 11
Th2 cells infiltrating high-grade serous ovarian cancer: a feature that may account for the poor prognosis.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 4, p. 1, doi. 10.3802/jgo.2023.34.e48
- By:
- Publication type:
- Article
Pattern of practice for postoperative management of endometrial cancer in Korea: a survey by the Korean Gynecologic Oncology Group and the Korean Radiation Oncology Group (KGOG 2028-KROG 2104).
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 4, p. 1, doi. 10.3802/jgo.2023.34.e54
- By:
- Publication type:
- Article
PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 4, p. 1, doi. 10.3802/jgo.2023.34.e53
- By:
- Publication type:
- Article
RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 4, p. 1, doi. 10.3802/jgo.2023.34.e50
- By:
- Publication type:
- Article
Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 4, p. 1, doi. 10.3802/jgo.2023.34.e49
- By:
- Publication type:
- Article
Histopathological subtyping of high- grade serous ovarian cancer using whole slide imaging.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 4, p. 1, doi. 10.3802/jgo.2023.34.e47
- By:
- Publication type:
- Article
Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 4, p. 1, doi. 10.3802/jgo.2023.34.e46
- By:
- Publication type:
- Article
RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 4, p. 1, doi. 10.3802/jgo.2023.34.e45
- By:
- Publication type:
- Article
Effectiveness and safety of nab- paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective study.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 4, p. 1, doi. 10.3802/jgo.2023.34.e44
- By:
- Publication type:
- Article
Reconstruction of the diaphragm with autologous fascia lata during cytoreduction in patients with advanced ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 4, p. 1, doi. 10.3802/jgo.2023.34.e43
- By:
- Publication type:
- Article
Adjuvant pelvic radiation versus observation in intermediate-risk early-stage cervical cancer patients following primary radical surgery: a propensity score-adjusted analysis.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 4, p. 1, doi. 10.3802/jgo.2023.34.e42
- By:
- Publication type:
- Article